Similar articles

• Mycobacterial adjuvant. I. Purification of an adjuvant-active component from wax D(H 37 Ra strain) by preparative thin-layer chromatography.

  Kumazawa Y, Tsushida A, Mizunoe K, Suzuki T, Kawanishi Y. Kumazawa Y, et al. Jpn J Microbiol. 1972 Jan;16(1):73-5. Jpn J Microbiol. 1972. PMID: 4625075 No abstract available.
• [Biological reactions induced by a lipopolysaccharide (wax D) of mycobacteria with special reference to adjuvant activity].

  Tanaka A. Tanaka A. Kekkaku. 1971 May;46(3):41-51. Kekkaku. 1971. PMID: 4994699 Japanese. No abstract available.
• Immunological adjuvants. V. A critical evaluation of minimal requirements for mycobacterial adjuvants to induce delayed hypersensitivity.

  Ishibashi T, Hagimoto D, Shinozaki S, Tanaka A, Sugiyama K. Ishibashi T, et al. Jpn J Exp Med. 1971 Apr;41(2):95-102. Jpn J Exp Med. 1971. PMID: 4994872 No abstract available.
• Nonliving immunogenic substances of Mycobacteria.

  Smith DW, Grover AA, Wiegeshaus E. Smith DW, et al. Bibl Tuberc. 1968;24:191-227. Bibl Tuberc. 1968. PMID: 4983194 Review. No abstract available.
• [25 years progress in tubercule bacillus research--report of tuberculosis panels in silver jubilee of the Japan-U.S. Cooperative Medical Science Program].

  Azuma I. Azuma I. Kekkaku. 1991 May;66(5):361-5. Kekkaku. 1991. PMID: 1908535 Review. Japanese. No abstract available.